Drug intelligence / Profile preview

d-fraction polysaccharide

Development stage
Unknown
Lead developer
Mushroom Wisdom
Administration
Oral, Intravenous, Subcutaneous, Infusion
01

Overview

D-fraction polysaccharide is a **protein-bound beta-glucan polysaccharide extract** from the maitake mushroom (*Grifola frondosa*), containing 1,3- and 1,6-beta-glucans as its main active components[5][2][3]. It exhibits **immunomodulatory, antitumor, and potential antidepressant activities**. D-fraction enhances immune functions by modulating natural killer (NK) cells, T-cells, and macrophages, and inhibits tumor growth in animal models and some human studies, with demonstrated activity in breast, prostate, lung, and liver cancers[5][2][1]. It may work as an adjunct in cancer therapy, helping mitigate side effects of chemotherapy and improving quality of life[5]. D-fraction also shows potential in management of chronic fatigue syndrome, HIV/AIDS, and metabolic conditions like diabetes and hypercholesterolemia[5][2]. Experimental evidence suggests a rapid-acting, long-lasting antidepressant effect in animals, with possible reduction of inflammatory pain symptoms[3]. D-fraction appears to be well tolerated, with no significant adverse effects reported[3][5].

Brand names
Maitake D-FractionD-fraction
Other names
Maitake PDFMaitake D-fractionMaitake polysaccharide D-fractionprotein-bound polysaccharide (Maitake)
02

Targets

αMβ2 (Integrin αMβ2)CLEC7A (Dectin-1)LacCer (Lactosylceramide)CD36 (CD36 antigen)

Beyond the preview

Go deeper on d-fraction polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on d-fraction polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call